Altered urinary tryptophan metabolites in alcohol‐associated liver disease

Author:

Xu Raobo1234ORCID,Vatsalya Vatsalya25,He Liqing1234ORCID,Ma Xipeng1234,Feng Wenke2356,McClain Craig J.23567ORCID,Zhang Xiang12346ORCID

Affiliation:

1. Department of Chemistry University of Louisville Louisville Kentucky USA

2. University of Louisville Alcohol Research Center University of Louisville Louisville Kentucky USA

3. University of Louisville Hepatobiology and Toxicology Center of Biomedical Research Excellence University of Louisville Louisville Kentucky USA

4. Center for Regulatory and Environmental Analytical Metabolomics University of Louisville Louisville Kentucky USA

5. Department of Medicine University of Louisville Louisville Kentucky USA

6. Department of Pharmacology and Toxicology University of Louisville Louisville Kentucky USA

7. Robley Rex Louisville VAMC Louisville Kentucky USA

Abstract

AbstractBackgroundAlcohol‐associated liver disease (ALD) leads to millions of deaths worldwide annually. A few potential biomarkers of ALD have been discovered through metabolomic or proteomic analysis. Tryptophan (Trp), one of nine essential amino acids, has been extensively studied and shown to play significant roles in many mammalian physiological processes. However, Trp metabolism changes in ALD are not yet fully understood. Whereas urine is an abundant and non‐invasive source for disease biomarker discovery the current study investigated whether the abundance of Trp metabolites in the urine of ALD patients differs from that of healthy subjects. We also examined whether, if present in ALD, changes in urinary Trp metabolites can serve as markers for differentiating between mild/moderate and severe ALD.MethodsWe quantified the concentration of Trp and its metabolites in urine samples of healthy controls (n = 18), patients with mild or moderate alcohol‐related liver injury (non‐severe ALD; n = 21), and patients with severe alcohol‐associated hepatitis (severe AH; n = 25) using both untargeted and targeted metabolomics.ResultsEighteen Trp metabolites were identified and quantified from the untargeted metabolomics data. We developed a targeted metabolomics method to quantify the Trp and its metabolites and quantified 17 metabolites from the human urine samples. The data acquired in the untargeted and targeted platforms agreed and showed that the Trp concentration is not affected by the severity of ALD. However, the abundance of 10 Trp metabolites was correlated with the model for end‐stage liver disease (MELD) score, with the abundance of nine metabolites significantly different between the healthy control and ALD patient groups.ConclusionWe found that Trp metabolism differs between ALD patients and healthy controls even though the concentration of Trp was not affected. Two Trp metabolites, quinolinic acid and indoxyl sulfate, correlate highly with the severity of ALD.

Funder

National Institutes of Health

U.S. Department of Veterans Affairs

Publisher

Wiley

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3